Compare Stocks

→ Biden replacement revealed? (From Paradigm Press) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MEDP Medpace	$386.34 +0.2%	$394.11	$202.02 ▼ $421.00	$11.97B	1.4	166,688 shs	292,758 shs

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MEDP Medpace	0.00%	-1.08%	-1.21%	-4.43%	+86.66%

The Only Energy Play You Should Be Looking At (Ad)

Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.

Click here to get all the information about it.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
MEDP Medpace	4.9591 of 5 stars	3.4	4.0	0.0	4.6	2.1	4.2	3.1

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MEDP Medpace	2.86	Moderate Buy	$443.14	14.70% Upside

Current Analyst Ratings

Latest MEDP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/29/2024	MEDP Medpace	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$452.00
5/28/2024	MEDP Medpace	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$435.00
4/24/2024	MEDP Medpace	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$453.00 ➝ $464.00
4/24/2024	MEDP Medpace	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$446.00 ➝ $454.00
4/23/2024	MEDP Medpace	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$340.00 ➝ $450.00
3/18/2024	MEDP Medpace	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold	$395.00

(Data available from 6/2/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MEDP Medpace	$1.96B	6.10	$10.07 per share	38.35	$21.67 per share	17.83

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MEDP Medpace	$282.81M	$9.81	39.38	29.42	1.91	15.92%	59.74%	19.70%	7/22/2024 (Estimated)

Latest MEDP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/22/2024	Q1 2024	MEDP Medpace	$2.45	$3.20	+$0.75	$3.20	$512.39 million	$511.00 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
MEDP Medpace	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MEDP Medpace	N/A	0.78	0.78

Ownership

Institutional Ownership

Company	Institutional Ownership
MEDP Medpace	77.98%

Insider Ownership

Company	Insider Ownership
MEDP Medpace	20.30%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
MEDP Medpace	5,900	30.98 million	24.69 million	Optionable

MEDP Headlines

Recent News About These Companies

June 1 at 9:41 PM | marketbeat.com

Eagle Asset Management Inc. Increases Position in Medpace Holdings, Inc. (NASDAQ:MEDP)

June 1 at 3:54 AM | marketbeat.com

Medpace Holdings, Inc. (NASDAQ:MEDP) Given Average Recommendation of "Moderate Buy" by Brokerages

May 31 at 5:34 PM | marketbeat.com

Evoke Wealth LLC Takes $3.15 Million Position in Medpace Holdings, Inc. (NASDAQ:MEDP)

May 31 at 5:04 AM | americanbankingnews.com

Medpace Holdings, Inc. (NASDAQ:MEDP) CEO Sells $2,252,315.55 in Stock

May 30 at 8:12 AM | americanbankingnews.com

Medpace Holdings, Inc. (NASDAQ:MEDP) CEO August J. Troendle Sells 3,987 Shares

May 30 at 7:37 AM | insidertrades.com

Medpace Holdings, Inc. (NASDAQ:MEDP) CEO Sells $1,575,742.14 in Stock

May 30 at 4:44 AM | americanbankingnews.com

Medpace (NASDAQ:MEDP) Now Covered by Analysts at TD Cowen

May 29, 2024 | msn.com

TD Cowen Initiates Coverage of Medpace Holdings (MEDP) with Buy Recommendation

May 29, 2024 | zacks.com

Here is Why Growth Investors Should Buy Medpace (MEDP) Now

May 29, 2024 | marketbeat.com

TD Asset Management Inc Acquires 308,816 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)

May 29, 2024 | marketbeat.com

TD Cowen Begins Coverage on Medpace (NASDAQ:MEDP)

May 29, 2024 | msn.com

Mizuho Initiates Coverage of Medpace Holdings (MEDP) with Buy Recommendation

May 28, 2024 | zacks.com

Medpace (MEDP) Rises Higher Than Market: Key Facts

May 28, 2024 | americanbankingnews.com

Medpace (NASDAQ:MEDP) Coverage Initiated at Mizuho

May 28, 2024 | marketbeat.com

Norges Bank Makes New $59.16 Million Investment in Medpace Holdings, Inc. (NASDAQ:MEDP)

May 27, 2024 | finance.yahoo.com

Should You Investigate Medpace Holdings, Inc. (NASDAQ:MEDP) At US$391?

May 26, 2024 | insidertrades.com

Medpace Holdings, Inc. (NASDAQ:MEDP) CEO Sells $22,000.00 in Stock

May 26, 2024 | marketbeat.com

Janney Montgomery Scott LLC Boosts Stock Position in Medpace Holdings, Inc. (NASDAQ:MEDP)

May 25, 2024 | marketbeat.com

Congress Wealth Management LLC DE Sells 4,277 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)

May 24, 2024 | marketbeat.com

Insider Selling: Medpace Holdings, Inc. (NASDAQ:MEDP) CEO Sells 55 Shares of Stock

May 24, 2024 | marketbeat.com

Medpace (NASDAQ:MEDP) Stock Price Up 1.1%

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Medpace

NASDAQ:MEDP

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial